Last updated on November 2017

Bipolar Depression study with 6-month open-label therapy

Brief description of study

Bipolar Depression study with 6-month open-label therapy

Detailed Study Description

If you or someone you know suffers from bipolar depression, you may be eligible to participate in a research medication study. This study consists of 8 weeks followed by 6 months of open-label therapy. Qualified participants are eligible to receive the following at no cost: study medication, medical and psychiatric assessments, lab work and sessions with a physician and/or a clinical study coordinator.

Patient Inclusion/Exclusion Criteria:

  • Males and females 18 years and older.
  • Subjects must be diagnosed with bipolar depression
  • Must have experienced at least one previous manic or mixed episode
  • Subjects must not have any serious, unstable illnesses or have substance dependence within the past 30 days.

Clinical Study Identifier: TX16024

Contact Investigators or Research Sites near you

Start Over

Carol Shreve

Bayou City Research Corporation
Houston, TX USA